Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Boxer
C V Dang

Oncogene

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Oncogene|October 19, 2001
Translocations involving c-myc and c-myc functionL M Boxer, C V Dang
Oncogene|September 1, 1994
Differential protein binding to the c-myc promoter during differentiation of hematopoietic cell linesM Arcinas, L M Boxer
Oncogene|October 18, 2006
The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cellsH Duan, C A Heckman, L M Boxer
Oncogene|August 13, 2008
Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cellsH Duan, H Xiang, L Ma, et al.
Oncogene|September 28, 2005
Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expressionC A Heckman, H Duan, P B Garcia, et al.
Oncogene|April 21, 2001
Negative regulation of bcl-2 expression by p53 in hematopoietic cellsY Wu, J W Mehew, C A Heckman, et al.
Oncogene|January 10, 2002
The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cellsC Li, T E Ahlborn, K Tokita, et al.
Oncogene|March 20, 1997
Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cellsM Cañelles, M D Delgado, K M Hyland, et al.
Oncogene|October 11, 2001
c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuliF Kuttler, P Amé, H Clark, et al.
Oncogene|December 1, 1990
A potential transcriptional activation element in the p53 proteinR W O'Rourke, C W Miller, G J Kato, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncogene|October 19, 2001
Translocations involving c-myc and c-myc functionL M Boxer, C V Dang
Oncogene|September 1, 1994
Differential protein binding to the c-myc promoter during differentiation of hematopoietic cell linesM Arcinas, L M Boxer
Oncogene|October 18, 2006
The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cellsH Duan, C A Heckman, L M Boxer
Oncogene|August 13, 2008
Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cellsH Duan, H Xiang, L Ma, et al.
Oncogene|September 28, 2005
Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expressionC A Heckman, H Duan, P B Garcia, et al.
Oncogene|April 21, 2001
Negative regulation of bcl-2 expression by p53 in hematopoietic cellsY Wu, J W Mehew, C A Heckman, et al.
Oncogene|January 10, 2002
The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cellsC Li, T E Ahlborn, K Tokita, et al.
Oncogene|March 20, 1997
Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cellsM Cañelles, M D Delgado, K M Hyland, et al.
Oncogene|October 11, 2001
c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuliF Kuttler, P Amé, H Clark, et al.
Oncogene|December 1, 1990
A potential transcriptional activation element in the p53 proteinR W O'Rourke, C W Miller, G J Kato, et al.
Pageof 1